Prospects of antigen-specific therapy in type 1 diabetes mellitus

Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents a...

Full description

Bibliographic Details
Main Authors: Tatiana Vasil'evna Nikonova, Yulia Viktorovna Alekseeva
Format: Article
Language:English
Published: Endocrinology Research Centre 2012-12-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/5534
_version_ 1797255241715941376
author Tatiana Vasil'evna Nikonova
Yulia Viktorovna Alekseeva
author_facet Tatiana Vasil'evna Nikonova
Yulia Viktorovna Alekseeva
author_sort Tatiana Vasil'evna Nikonova
collection DOAJ
description Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents approved for clinical practice. However, ongoing large-scale studies have outlined some promising solutions, antigen-specific immunotherapy being one of them.
first_indexed 2024-03-08T15:21:48Z
format Article
id doaj.art-dcc7b58ce30f498f8bd52c9a5e94510c
institution Directory Open Access Journal
issn 2072-0351
2072-0378
language English
last_indexed 2024-04-24T22:02:44Z
publishDate 2012-12-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj.art-dcc7b58ce30f498f8bd52c9a5e94510c2024-03-20T11:47:58ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782012-12-01154283210.14341/2072-0351-55345492Prospects of antigen-specific therapy in type 1 diabetes mellitusTatiana Vasil'evna Nikonova0Yulia Viktorovna Alekseeva1Endocrinology Research CentreEndocrinology Research CentreType 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents approved for clinical practice. However, ongoing large-scale studies have outlined some promising solutions, antigen-specific immunotherapy being one of them.https://www.dia-endojournals.ru/jour/article/view/5534gad65hsp60diamyddiapep277diabetes mellitus type 1vaccinationgad65hsp60insulindiamyddiapep277
spellingShingle Tatiana Vasil'evna Nikonova
Yulia Viktorovna Alekseeva
Prospects of antigen-specific therapy in type 1 diabetes mellitus
Сахарный диабет
gad65
hsp60
diamyd
diapep277
diabetes mellitus type 1
vaccination
gad65
hsp60
insulin
diamyd
diapep277
title Prospects of antigen-specific therapy in type 1 diabetes mellitus
title_full Prospects of antigen-specific therapy in type 1 diabetes mellitus
title_fullStr Prospects of antigen-specific therapy in type 1 diabetes mellitus
title_full_unstemmed Prospects of antigen-specific therapy in type 1 diabetes mellitus
title_short Prospects of antigen-specific therapy in type 1 diabetes mellitus
title_sort prospects of antigen specific therapy in type 1 diabetes mellitus
topic gad65
hsp60
diamyd
diapep277
diabetes mellitus type 1
vaccination
gad65
hsp60
insulin
diamyd
diapep277
url https://www.dia-endojournals.ru/jour/article/view/5534
work_keys_str_mv AT tatianavasilevnanikonova prospectsofantigenspecifictherapyintype1diabetesmellitus
AT yuliaviktorovnaalekseeva prospectsofantigenspecifictherapyintype1diabetesmellitus